Intravenous injection
An injection directly into a vein, providing immediate systemic bioavailability. Rarely used for self-administered peptides but common in clinical settings for research peptides and NAD+ infusions.
Frequently Asked Questions
What is Intravenous injection?
An injection directly into a vein, providing immediate systemic bioavailability. Rarely used for self-administered peptides but common in clinical settings for research peptides and NAD+ infusions.
Why is Intravenous injection important in peptide research?
Understanding intravenous injection is essential for safe and effective peptide use. Proper administration technique directly impacts peptide bioavailability, therapeutic outcomes, and minimizes the risk of adverse effects or contamination.
Related Terms
Bioavailability
The fraction of an administered dose that reaches systemic circulation unchanged. Subcutaneous injection provides 65–95% bioavailability for most peptides; oral bioavailability is typically below 1% without absorption enhancers.
Bolus injectionA single, relatively rapid injection of a peptide as opposed to a slow infusion. Most subcutaneous peptide administrations are bolus injections.
Continuous infusionSlow, sustained delivery of a peptide over an extended period using an infusion pump or IV drip. Used in clinical settings for NAD+ infusions and some research peptides.